US equities |
INTC $64.66 ▼-29.77% AMZN $239.30 ▼-1.84% MU $882.13 ▼-5.58% NVDA $204.47 ▼-4.30% SNDK $1,165.84 ▼-12.35% GOOGL $280.51 ▼-1.17% AMD $502.15 ▼-11.35% SPCX $137.70 ▼-4.30%
FinancialContent

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.2936 +0.0161 (+5.80%)
Delayed Quote Updated: 12:29 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
Via ACCESSWIRE
News headline image
Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product
Via ACCESSWIRE
News headline image
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
Via ACCESSWIRE
News headline image
Over $5M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying ↗
Although U.S. stocks closed lower on Thursday following the CPI data, there were a few notable insider trades. 
Via Benzinga
News headline image
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders
Via ACCESSWIRE
News headline image
Why Is Nutraceuticals Player Cosmos Health Stock Trading Higher Today? ↗
Cosmos Health Inc (NASDAQ: COSM) announced its inaugural 2026 revenue and  
Via Benzinga
News headline image
COSMOS HEALTH CEO Issues Letter to Shareholders
Via ACCESSWIRE
News headline image
Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done ↗
The healthcare industry has historically provided good returns to investors, however there are also healthcare stocks you will want to sell. 
Via InvestorPlace
News headline image
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company
Via ACCESSWIRE
News headline image
Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market
Via ACCESSWIRE
News headline image
Cosmos Health Announces Relaunch of bio-bebe(R), its Proprietary Organic Infant Care &amp; Nutrition Brand; Aims to Penetrate $103bn Global Baby Food Market
Via ACCESSWIRE
News headline image
Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group
Via ACCESSWIRE
News headline image
Cosmos Health Starts Stock Buyback Program
Via ACCESSWIRE
BestGrowthStocks.com issues New Growth Report on Cosmos Health
--News Direct-- 
Via News Direct
BestGrowthStocks.com issues New Growth Report on Cosmos Health
NEW YORK, NY / NewsDirect / September 13th, 2023 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks... 
Via TheNewswire.com
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023
Via ACCESSWIRE
News headline image
Cosmos Health Q2: Revenues Slip 6%, Unfavorable Forex, Positive Adjusted EBITDA & More ↗
Cosmos Health Inc. (NASDAQ: COSM) reported 
Via Benzinga
News headline image
Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04
Via ACCESSWIRE
News headline image
Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor
Via ACCESSWIRE
News headline image
Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain
Via ACCESSWIRE
News headline image
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Quarter ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  Wednesday saw 59 companies set new 52-week lows. 
Via Benzinga
News headline image
Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million
Via ACCESSWIRE
News headline image
Cosmos Health And 2 Other Penny Stocks Insiders Are Buying ↗
The Dow Jones closed higher on Monday, recording gains for the eleventh straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.... 
Via Benzinga
News headline image
Cosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. 
Via Benzinga
News headline image
Why Cosmos Health (COSM) Stock Is Nosediving ↗
Cosmos Health Inc. (NASDAQ: COSM) shares are trading lower by 17.3% to $2.05 Thursday morning after the company priced its $5.25 million registered direct offering and concurrent private placement at... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >